Profiling of Toca-1 levels in human breast tumors revealed high Toca-1 levels in HER2 and TNBC that frequently harbor p53 mutations, and high Toca-1 transcript levels were associated with increased risk of relapse in patients with TNBC. Here, TP53 is linked to breast neoplasm.